Urolithiasis Management Devices Market to Grow with a CAGR of 4.77% through 2029

Increasing prevalence of kidney stones and advancements in medical technology are factors driving the Global Urolithiasis Management Devices market in the forecast period 2025-2029

According to TechSci Research report, “Urolithiasis Management Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Urolithiasis Management Devices Market stood at USD 1.53 billion in 2023 and is anticipated to grow with a CAGR of 4.77% in the forecast period, 2025-2029. This can be attributed to a continuous rise in occurrence. Kidney stones are not a new health concern, but their prevalence has been continuously rising since the early 20th century. Factors such as dietary changes, sedentary lifestyles, and increased consumption of certain foods have contributed to the consistent growth in urolithiasis cases. This steady increase in incidence has translated into an ongoing demand for cutting-edge urolithiasis management devices.

The efforts to expand access to urolithiasis management devices are gaining momentum. Initiatives are underway to ensure that even underserved regions have access to the latest technology and treatment options. Bridging the access gap is crucial for addressing global disparities in urolithiasis care.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Urolithiasis Management Devices Market”

According to NHS inform, the age group most commonly affected by kidney stones falls between 30 and 60 years old. Kidney stones are prevalent, impacting about three out of 20 males and up to two out of 20 females at some point in their lives. Medically referred to as nephrolithiasis, the excruciating pain caused by kidney stones is termed renal colic. A May 2023 report from St. Pete Urology indicates that approximately 500,000 individuals in the United States seek emergency treatment for kidney stones each year.

The behaviors such as increased alcohol consumption and reduced water intake, often associated with sedentary lifestyles, can contribute to the development of kidney stones. The growing prevalence of obesity, a high-risk factor for kidney stone formation, is linked to sedentary living, poor dietary habits, and a lack of physical activity, further fueling the demand for urolithiasis management devices. As reported by the European Association of Urology, kidney stones affect about 10% of the global population. The recurrence rate of this condition is around 50% over a patient's lifetime. The increasing incidence and prevalence of urinary stones, coupled with the global preference for minimally invasive procedures, are key factors driving the demand for urolithiasis management methods.

Urinary stones can be categorized based on size, location within the body, and anatomical characteristics of the urogenital tract. Treatment strategies are tailored to patient needs, taking into account stone size, which is typically classified as up to 5 mm, 5-10 mm, 10-20 mm, and >20 mm or larger. The global market for urolithiasis management devices offers various treatment options, including Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, and other treatments.

Typical approaches to kidney stone treatment encompass medication, dietary adjustments, and in more severe cases, surgical procedures. The effectiveness of each treatment method is influenced by factors such as the size, composition, and underlying cause of the kidney stones. Simple measures like medication and increased hydration can facilitate the passage of small stones with minimal discomfort. However, larger stones may necessitate surgical interventions like ureteroscopy or extracorporeal shock wave lithotripsy (ESWL).

The Global Urolithiasis Management Devices Market is segmented into treatment type, end use, regional distribution, and company.

Based on treatment type, the intracorporeal lithotripsy sector emerged as the dominant force in the market. This is ascribed due to its effectiveness and versatility in treating kidney stones. This minimally invasive procedure involves the use of devices such as laser probes, ultrasonic lithotripters, or pneumatic lithotripters to fragment stones within the urinary tract, allowing for easier removal or passage. Compared to traditional surgical techniques, intracorporeal lithotripsy offers faster recovery times, reduced risk of complications, and improved patient outcomes. Its ability to target stones of varying sizes and compositions, coupled with advancements in device technology and surgical techniques, has solidified its position as a preferred treatment option for kidney stone management.

Conversely, in 2023, the ESWL segment secured a significant share of the revenue. ESWL remains a widely used, minimally invasive treatment due to its accessibility and cost-effectiveness. This technique primarily employs shock waves to break down stones with diameters ranging from 4 mm to 2 cm into smaller pieces, facilitating their passage from the body. Typically, ESWL is conducted on an outpatient basis, eliminating the need for a hospital stay. It is particularly effective for relatively smaller urinary stones, which are prevalent among stone-afflicted patients. The shock wave generators employed in this method include electrohydraulic, piezoelectric, and electromagnetic devices.

Based on end use, the "Hospitals & Clinics" dominated the market in 2023. This is ascribed due to their role as primary centers for diagnosing and treating kidney stone disease. These healthcare facilities possess advanced medical equipment, skilled healthcare professionals, and comprehensive diagnostic and treatment capabilities essential for managing urolithiasis effectively. Hospitals and clinics serve as referral centers for complex cases and surgical interventions, further consolidating their dominance in the market. Their ability to provide integrated care, including access to cutting-edge urolithiasis management devices and surgical expertise, makes them preferred destinations for patients seeking optimal treatment outcomes for kidney stone disease.

On the other hand, the "Ambulatory Surgical Centers (ASCs)" category is anticipated to experience the most rapid CAGR throughout the projected period. When dealing with large obstructive urinary stones, surgical removal becomes a necessary option. Ambulatory surgical centers are gradually gaining popularity due to their time-saving and cost-effective treatment alternatives, which reduce extended hospital stays. Technological advancements in the field of surgery, including the availability of minimally invasive tools such as endoscopes and precision instruments, enable urologists to carry out painless stone removal procedures. The preference for ambulatory surgical centers for treating urinary stones is expected to be notably higher in developed countries like the United States, Canada, the United Kingdom, and Germany, primarily because of their convenient accessibility.

Major companies operating in Global Urolithiasis Management Devices Market are:

·         Allengers Medical Systems Ltd

·         Boston Scientific Corp

·         Cook Medical Inc

·         CONMED Corp

·         DiREX CORP

·         Dornier MedTech GmbH

·         HealthTronics Inc

·         Karl Storz SE & Co KG

·         Lumenis Inc

·         Siemens Healthcare Ltd

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The global urolithiasis management devices market is poised for remarkable growth and innovation. Key trends include the shift towards minimally invasive procedures, personalized treatment plans, telemedicine adoption, innovative device development, data-driven care, and an emphasis on patient-centered care. The growing focus on preventive measures, improved global access, cross-disciplinary collaboration, and sustainability in healthcare further contribute to the changing landscape of urolithiasis management. As these trends continue to evolve, patients can expect a higher standard of care and more advanced treatment options for managing kidney stones. The future of urolithiasis management is characterized by a commitment to patient well-being, innovative technologies, and a global approach to care,” said Mr. Karan Chechi, Research Director, TechSci Research, a research-based management consulting firm.

“Urolithiasis Management Devices Market By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region, By Competition Forecast & Opportunities, 2019-2029F”, has evaluated the future growth potential of Global Urolithiasis Management Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Urolithiasis Management Devices Market.

 Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]

Website: www.techsciresearch.com